Background illustration for clinical trials search

Pancreatic Cancer Clinical Trials

Browse 1,722 pancreatic cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer

for
Pancreatic Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT02361320

Recruiting

Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas Cancer

for
Pancreatic Neoplasms
Location: Houston TX
Sponsor: The University of Texas Health Science Center, Houston

Sex: All

Age: 18+

Code: NCT00178763

Phase 2, Recruiting

A Study of CPI-613 With Gemcitabine and Nab-paclitaxel for Patients With Advanced or Metastatic Pancreatic Cancer

for
Pancreatic Cancer, Metastatic Pancreatic Cancer
Location: Summit NJ, Morristown NJ
Sponsor: Atlantic Health System

Sex: All

Age: 18+

Code: NCT03435289

Phase 1, Recruiting

Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts

for
Pancreatic Carcinoma
Location: Boston MA, Baltimore MD, Pittsburgh PA, Atlanta GA,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06271291

Recruiting

Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study

for
Chronic Pancreatitis, Exocrine Pancreas Carcinoma,
Location: Boston MA, Montreal, Philadelphia PA, Baltimore MD,
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0 - 17

Code: NCT06651580

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Intraoperative Radiation Therapy for Resectable Pancreas Cancer

for
Pancreas Cancer
Location: Maywood IL
Sponsor: Loyola University

Sex: All

Age: 18+

Code: NCT02599662

Phase 1, Recruiting

Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk

for
Pancreatic Cancer
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 18+

Code: NCT02478892

Recruiting

Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer

for
Pancreatic Cancer Metastatic
Location: Brooklyn NY
Sponsor: State University of New York - Downstate Medical Center

Sex: All

Age: 18+

Code: NCT06030622

Phase 1, Phase 2, Recruiting

Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer

for
Pancreatic Cancer Non-resectable, Pancreatic Cancer Metastatic,
Location: Saint Louis Park MN
Sponsor: HealthPartners Institute

Sex: All

Age: 18+

Code: NCT06605430

Phase 2, Recruiting

Disposable Perfusion Phantom for Accurate DCE (Dynamic Contrast Enhanced)-MRI Measurement of Pancreatic Cancer Therapy Response

for
Pancreatic Cancer
Location: Columbus OH, Nashville TN
Sponsor: Ohio State University

Sex: All

Age: 19+

Code: NCT04588025

Recruiting

Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer

for
Colorectal Neoplasms, Gastric Neoplasms, Cholangiocarcinoma,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 2+

Code: NCT01915225

Recruiting

Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer

for
Metastatic Pancreatic Cancer
Location: Boca Raton FL, Pittsburgh PA, Greenville SC, Tyler TX,
Sponsor: Cantex Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT05766748

Phase 1, Phase 2, Recruiting

Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach

for
Pancreatic Cancer
Location: Cleveland OH, Birmingham AL, St Louis MO, Duarte CA
Sponsor: Varian, a Siemens Healthineers Company

Sex: All

Age: 18+

Code: NCT05764720

Recruiting

Evaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE Study

for
Pancreatic Neoplasm
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT05961982

Recruiting

Evaluating the Prognostic Capability of ctDNA as a Biomarker in Pancreatic Cancer Patients Undergoing Neoadjuvant Chemotherapy

for
Pancreas Cancer
Location: Warrenville IL, Geneva IL, DeKalb IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT04616131

Recruiting

Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial

for
Pancreas Cancer, Oligometastatic
Location: Voorhees Township NJ, Camden NJ, Houston TX, Dallas TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06593431

Phase 3, Recruiting

Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers

for
Hepatobiliary Cancer, Pancreatic Cancer,
Location: Orange CA
Sponsor: University of California, Irvine

Sex: All

Age: 18+

Code: NCT05497531

Recruiting

Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms

for
Pancreatic Neuroendocrine Neoplasm
Location: San Diego CA, Los Angeles CA, San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT05746182

Recruiting

T-EUS for Gastrointestinal Disorders: A Multicenter Registry

for
Cholangiocarcinoma, Pancreatic Cancer, Bile Duct Cancer,
Location: New York NY
Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 18+

Code: NCT01522573

Recruiting

A Study of DM002 in Patients With Advanced Solid Tumors

for
Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms,
Location: Huntersville NC, Houston TX, Oklahoma City OK,
Sponsor: Xadcera Biopharmaceutical (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06751329

Phase 1, Phase 2, Recruiting

What is pancreatic cancer?

The pancreas sits deep behind the stomach and makes both digestive enzymes and hormones like insulin. About 92 percent of pancreatic cancers start in the enzyme making cells, and this page is mostly about those. The other 8 percent are neuroendocrine tumors, which grow more slowly, have their own trials, and a five year survival of 72 percent against 8 percent. The pancreas gives no early warning. Jaundice, back pain, weight loss and new diabetes usually appear only after the cancer has grown or spread, and fewer than 20 percent of people can have surgery at diagnosis.

Smoking roughly doubles the risk, and type 2 diabetes, extra weight, chronic pancreatitis and family history raise it. About 10 percent of cases come from inherited mutations, so guidelines now recommend genetic testing for everyone diagnosed. That can change treatment and flag relatives who should be watched. The hope comes from biology. More than 90 percent of pancreatic cancers carry a KRAS mutation. That target was called undruggable for decades. Now several RAS inhibitors are in trials, with the first Phase 3 studies recruiting. Pancreatic cancer shares risk factors with type 2 diabetes and inherited genes with breast and ovarian cancer.

Article preview image

Our guide to new treatments for pancreatic cancer covers what has been approved and what is being tested.

Research Paving The Way To A New Treatment For Pancreatic Cancer

Types of pancreatic cancer clinical trials

Who can participate in pancreatic cancer clinical trials?

What causes pancreatic cancer?

The stages of pancreatic cancer, and why they matter for trials

How to enroll in a pancreatic cancer clinical trial